Broad US-patent issued to MediGene
Patent protects novel methods for production of therapeutic viruses
19-Sep-2001 -
The German-American
biopharmaceutical company MediGene (NMarkt: MDG) announced today a
significant addition to its intellectual property portfolio with the grant of
US-Patent US 6,277,621. This patent gives MediGene broad protection
covering the use of bacterial artificial chromosomes (BAC) ...
brain cancer
cardiology
chromosomes
+12